Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer

F Fatima Cardoso S Susanne Parke (Bayer, Berlin) D Donal J. Brennan (University College Dublin Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin) P Paula Briggs (Liverpool Women’s Hospital, Liverpool, United Kingdom) G Gilbert Donders (Department of Clinical Research for Women, Femicare, Tienen, Belgium) N Nick Panay (Queen Charlotte’s and Chelsea Hospital, Imperial College London, London) N Nazanin Haseli-Mashhadi (Bayer, Reading, United Kingdom) M Michael Block (Bayer, Leverkusen, Germany) C Cecilia Caetano (Bayer, Basel, Switzerland) M Maja Francuski (Bayer, Berlin) C Claudia Haberland (Bayer, Berlin) K Kaisa Laapas (Bayer, Espoo, Finland) C Christian Seitz L Lineke Zuurman (Bayer, Basel, Switzerland)

Article Details

Volume / Issue Vol. 393, Issue 8
Published August 21, 2025
Pages 753-763
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (14)

F

Fatima Cardoso

S

Susanne Parke

Bayer, Berlin

D

Donal J. Brennan

University College Dublin Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin

P

Paula Briggs

Liverpool Women’s Hospital, Liverpool, United Kingdom

G

Gilbert Donders

Department of Clinical Research for Women, Femicare, Tienen, Belgium

N

Nick Panay

Queen Charlotte’s and Chelsea Hospital, Imperial College London, London

N

Nazanin Haseli-Mashhadi

Bayer, Reading, United Kingdom

M

Michael Block

Bayer, Leverkusen, Germany

C

Cecilia Caetano

Bayer, Basel, Switzerland

M

Maja Francuski

Bayer, Berlin

C

Claudia Haberland

Bayer, Berlin

K

Kaisa Laapas

Bayer, Espoo, Finland

C

Christian Seitz

L

Lineke Zuurman

Bayer, Basel, Switzerland